Compounds > enzastaurin
Page last updated: 2024-09-05

enzastaurin and ophiocordin

enzastaurin has been researched along with ophiocordin in 1 studies

Compound Research Comparison

Studies
(enzastaurin)		Trials
(enzastaurin)		Recent Studies (post-2010)
(enzastaurin)		Studies
(ophiocordin)		Trials
(ophiocordin)		Recent Studies (post-2010) (ophiocordin)
18852991103

Protein Interaction Comparison

ProteinTaxonomyenzastaurin (IC50)ophiocordin (IC50)
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.04
Protein kinase C gamma typeHomo sapiens (human)0.0148
Protein kinase C beta typeHomo sapiens (human)0.0199
Protein kinase C alpha typeHomo sapiens (human)0.0248
cAMP-dependent protein kinase catalytic subunit alphaHomo sapiens (human)0.027
Beta-adrenergic receptor kinase 1Bos taurus (cattle)0.035
cAMP-dependent protein kinase catalytic subunit gammaHomo sapiens (human)0.004
cAMP-dependent protein kinase catalytic subunit betaHomo sapiens (human)0.004
Protein kinase C eta typeHomo sapiens (human)0.0113
Beta-adrenergic receptor kinase 1Homo sapiens (human)0.042
Rhodopsin kinase GRK1Bos taurus (cattle)4.1
G protein-coupled receptor kinase 4Homo sapiens (human)0.26
G protein-coupled receptor kinase 5Homo sapiens (human)0.16
Beta-adrenergic receptor kinase 2Homo sapiens (human)0.047
G protein-coupled receptor kinase 5Bos taurus (cattle)0.44
G protein-coupled receptor kinase 6Homo sapiens (human)0.49
Protein kinase C epsilon typeHomo sapiens (human)0.0223
Protein kinase C zeta typeHomo sapiens (human)7.4
Protein kinase C delta typeHomo sapiens (human)0.0141
Rhodopsin kinase GRK1Homo sapiens (human)0.34
Rhodopsin kinase GRK7Homo sapiens (human)0.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alaoui-Jamali, MA; Amzil, H; Bijian, K; Lim, FPL; Miron, CE; Moitessier, N; Nivedha, AK; Su, J; Wernic, D1

Other Studies

1 other study(ies) available for enzastaurin and ophiocordin

ArticleYear
Novel Aurora A and Protein Kinase C (α, β1, β2, and θ) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Antineoplastic Agents; Aurora Kinase A; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen Bonding; Isoenzymes; Molecular Docking Simulation; Protein Kinase C; Protein Kinase Inhibitors; Selenium Compounds; Small Molecule Libraries; Structure-Activity Relationship; Substrate Specificity; Tumor Stem Cell Assay

2022